Massachusetts Financial Services’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $770K | Buy |
59,217
+731
| +1% | +$9.51K | ﹤0.01% | 834 |
|
|
2025
Q1 | $619K | Sell |
58,486
-1,331
| -2% | -$14.1K | ﹤0.01% | 835 |
|
|
2024
Q4 | $1.02M | Buy |
59,817
+10,860
| +22% | +$184K | ﹤0.01% | 817 |
|
|
2024
Q3 | $1.14M | Buy |
48,957
+10,728
| +28% | +$249K | ﹤0.01% | 788 |
|
|
2024
Q2 | $931K | Sell |
38,229
-2,897
| -7% | -$70.5K | ﹤0.01% | 802 |
|
|
2024
Q1 | $1.39M | Sell |
41,126
-91
| -0.2% | -$3.07K | ﹤0.01% | 756 |
|
|
2023
Q4 | $1.3M | Buy |
41,217
+3,457
| +9% | +$109K | ﹤0.01% | 752 |
|
|
2023
Q3 | $965K | Sell |
37,760
-1,447
| -4% | -$37K | ﹤0.01% | 762 |
|
|
2023
Q2 | $1.12M | Buy |
+39,207
| New | +$1.12M | ﹤0.01% | 742 |
|
|
2021
Q2 | – | Sell |
-8,483
| Closed | -$350K | – | 908 |
|
|
2021
Q1 | $350K | Sell |
8,483
-4,945
| -37% | -$204K | ﹤0.01% | 895 |
|
|
2020
Q4 | $583K | Sell |
13,428
-135
| -1% | -$5.86K | ﹤0.01% | 832 |
|
|
2020
Q3 | $582K | Buy |
+13,563
| New | +$582K | ﹤0.01% | 816 |
|